Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
March 24, 2022 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
- Confirmed partial response in one of the first three metastatic castration-resistant prostate cancer (mCRPC) patients treated with BPX-601 in Phase 1/2 study - - Favorable safety profile observed...
With a Two-Year Revenue Growth of 803%, OJO Labs Ranks No. 16 on Inc. Magazine’s List of the Southwest Region’s Fastest-Growing Private Companies
March 15, 2022 16:03 ET
|
OJO Labs
AUSTIN, Texas, March 15, 2022 (GLOBE NEWSWIRE) -- Inc. magazine today revealed that OJO Labs is No. 16 on its third annual Inc. 5000 Regionals Southwest list, the most prestigious ranking of the...
Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
January 26, 2022 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick...
Zev Asch Speaks About Disruptive Thinking for Small Business Owners
January 11, 2022 06:25 ET
|
Mission Matters Business Podcast
Beverly Hills , Jan. 11, 2022 (GLOBE NEWSWIRE) -- Zev Asch's mission and purpose are one and the same: to change the lives of business owners by helping them grow their companies and achieve a...
Bellicum Regains Compliance with Nasdaq Continued Listing Requirements
December 13, 2021 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that it has...
Aptive Environmental Recognized On Inc.’s 2021 Best in Business List
December 07, 2021 13:46 ET
|
Aptive Environmental
PROVO, Utah, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Aptive Environmental, one of the fastest-growing pest control companies in North America, has been recognized on the Inc. 2021 Best in Business list as...
Bellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Private Placement Equity Financing Priced at Market
December 06, 2021 07:30 ET
|
Bellicum Pharmaceuticals, Inc.
- Confirmed partial response observed in one patient in first cohort of metastatic castration-resistant prostate cancer (mCRPC) patients treated with BPX-601 - - Favorable safety profile observed in...
Engineered T Cells Market Research Report by Type, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
November 25, 2021 07:29 ET
|
ReportLinker
New York, Nov. 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Engineered T Cells Market Research Report by Type, by Application, by End User, by Region - Global...
Bellicum Reports Third Quarter 2021 Financial Results and Provides Operational Update
November 04, 2021 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
- Entered into additional licensing agreement with The University of Texas MD Anderson Cancer Center for use of CaspaCIDe® safety switch technology - - Charity Scripture, MS, PharmD, appointed Chief...
For the 12th Time, Access Recognized on the Inc. 5000, With Three-Year Revenue Growth of 43 Percent
November 03, 2021 12:15 ET
|
Access
WOBURN, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Access, the world’s largest privately-held integrated information management services provider, today announced that it is being recognized for the...